ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Neuland Laboratories reported Q1 FY27 total income of ₹650.1 crore and EBITDA of ₹231.1 crore. The company highlights strong performance across CMS and GDS businesses.
Neuland Laboratories reported FY26 total income of ₹2053.1 Crore and EBITDA of ₹603.4 Crore. Annual performance shows strong execution discipline and positive business visibility.